1. 000157 CHEMORADIATION AS A SPHINCTER SPARING TREATMENT FOR VULVAR CANCER. (1st September 2005) Authors: Drouin, P.; Jolicoeur, M.; Coffin, F.; Nguyen, T. V.; Devieux, A.; Gauthier, P.; Provencher, D. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 00046 CLINICAL IMPLICATIONS OF SENTINEL NODES IN EARLY CERVICAL CARCINOMA. (1st September 2005) Authors: Drouin, P.; Provencher, D.; Gauthier, P.; Sauthier, P.; Laflamme, L.; Lussier, C.; Luo, Z. C. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population. (22nd November 2014) Authors: Castellsagué, E.; Liu, J.; Volenik, A.; Giroux, S.; Gagné, R.; Maranda, B.; Roussel‐Jobin, A.; Latreille, J.; Laframboise, R.; Palma, L.; Kasprzak, L.; Marcus, V.A.; Breguet, M.; Nolet, S.; El‐Haffaf, Z.; Australie, K.; Gologan, A.; Aleynikova, O.; Oros‐Klein, K.; Greenwood, C. Journal: Clinical genetics Issue: Volume 87:Number 6(2015:Jun.) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose ranging study of monalizumab (IPH2201) in patients with gynecologic malignancies: A trial of the Canadian Cancer Trials Group (CCTG): IND221. (December 2016) Authors: Tinker, A.; Hirte, H.; Provencher, D.; Butler, M.; Ritter, H.; Tu, D.; Paralejas, P.; Grenier, N.; Hahn, S.; Ramsahai, J.; Seymour, L. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma. (4th October 2015) Authors: Chene, G.; Ouellet, V.; Rahimi, K.; Barres, V.; Meunier, L.; De Ladurantaye, M.; Provencher, D.; Mes-Masson, A. M. Other Names: Buonaguro Franco M. Academic Editor. Journal: BioMed research international Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC). (February 2017) Authors: Oaknin, A.; Oza, A.; Tinker, A.V.; Ray-Coquard, I.; Coleman, R.; O'Malley, D.; Shapira-Frommer, R.; Leary, A.; Chen, L.M.; Provencher, D.; Ma, L.; Brenton, J.; Balmaña, J.; Giordano, H.; Maloney, L.; Goble, S.; Rolfe, L.; McNeish, I.; Swisher, E.; Kristeleit, R.S. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy. Issue 2 (11th December 2015) Authors: Astolfi, M.; Péant, B.; Lateef, M. A.; Rousset, N.; Kendall-Dupont, J.; Carmona, E.; Monet, F.; Saad, F.; Provencher, D.; Mes-Masson, A.-M.; Gervais, T. Journal: Lab on a chip Issue: Volume 16:Issue 2(2016) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗